v3.26.1
Liability Related to Sale of Future Royalties (Tables)
6 Months Ended
Jun. 30, 2026
Liability Related to Sale of Future Royalties [Abstract]  
Liability Related to Sale of Future Royalties
The following table sets forth information on our liability related to sale of future royalties (in thousands):
 
Liability related to sale of future royalties, net as of December 31, 2025$563,042 
Royalty payments to Royalty Pharma (22,387
Interest expense related to sale of future royalties 34,538 
Amortization of issuance costs related to sale of future royalties 305 
Liability related to sale of future royalties, net as of June 30, 2026$575,498 
Less: Current portion (1) (12,924
Liability related to sale of future royalties, net as of June 30, 2026 – Non-current$562,574